Suppr超能文献

相似文献

1
Mcp1 Promotes Macrophage-Dependent Cyst Expansion in Autosomal Dominant Polycystic Kidney Disease.
J Am Soc Nephrol. 2018 Oct;29(10):2471-2481. doi: 10.1681/ASN.2018050518. Epub 2018 Sep 12.
2
Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease.
J Clin Invest. 2015 Jun;125(6):2399-412. doi: 10.1172/JCI80467. Epub 2015 May 11.
3
Tubular STAT3 Limits Renal Inflammation in Autosomal Dominant Polycystic Kidney Disease.
J Am Soc Nephrol. 2020 May;31(5):1035-1049. doi: 10.1681/ASN.2019090959. Epub 2020 Apr 1.
4
Haploinsufficiency of Pkd2 is associated with increased tubular cell proliferation and interstitial fibrosis in two murine Pkd2 models.
Nephrol Dial Transplant. 2006 Aug;21(8):2078-84. doi: 10.1093/ndt/gfl150. Epub 2006 May 23.
5
Cyclin-Dependent Kinase 1 Activity Is a Driver of Cyst Growth in Polycystic Kidney Disease.
J Am Soc Nephrol. 2021 Jan;32(1):41-51. doi: 10.1681/ASN.2020040511. Epub 2020 Oct 12.
7
Cux1 promotes cell proliferation and polycystic kidney disease progression in an ADPKD mouse model.
Am J Physiol Renal Physiol. 2017 Oct 1;313(4):F1050-F1059. doi: 10.1152/ajprenal.00380.2016. Epub 2017 Jul 12.
8
RNA helicase p68 inhibits the transcription and post-transcription of in ADPKD.
Theranostics. 2020 Jul 9;10(18):8281-8297. doi: 10.7150/thno.47315. eCollection 2020.
9
The chloride channel CFTR is not required for cyst growth in an ADPKD mouse model.
FASEB J. 2021 Oct;35(10):e21897. doi: 10.1096/fj.202100843R.
10
Macrophages promote cyst growth in polycystic kidney disease.
J Am Soc Nephrol. 2011 Oct;22(10):1809-14. doi: 10.1681/ASN.2011010084. Epub 2011 Sep 15.

引用本文的文献

1
Autosomal Dominant Polycystic Kidney Disease: From Pathogenesis to Organoid Disease Models.
Biomedicines. 2025 Jul 18;13(7):1766. doi: 10.3390/biomedicines13071766.
2
Microvascular aberrations found in human polycystic kidneys are an early feature in a Pkd1 mutant mouse model.
Dis Model Mech. 2025 Apr 1;18(4). doi: 10.1242/dmm.052024. Epub 2025 Apr 28.
4
Predicting Kidney Outcomes in Autosomal Dominant Polycystic Kidney Disease: A Comprehensive Biomarker Analysis.
Clin J Am Soc Nephrol. 2025 May 1;20(5):608-618. doi: 10.2215/CJN.0000000680. Epub 2025 Mar 11.
5
Autosomal Dominant Polycystic Kidney Disease Inflammation Biomarkers in the Tolvaptan Era.
Int J Mol Sci. 2025 Jan 28;26(3):1121. doi: 10.3390/ijms26031121.
6
Physiologic mechanisms underlying polycystic kidney disease.
Physiol Rev. 2025 Jul 1;105(3):1553-1607. doi: 10.1152/physrev.00018.2024. Epub 2025 Feb 12.
7
The impact of maternal obesity on polycystic kidney disease progression in a mouse model.
Am J Physiol Renal Physiol. 2025 Mar 1;328(3):F316-F327. doi: 10.1152/ajprenal.00227.2024. Epub 2025 Feb 5.
8
Kidney immunology from pathophysiology to clinical translation.
Nat Rev Immunol. 2025 Jan 30. doi: 10.1038/s41577-025-01131-y.
9
Intestinal barrier function declines during polycystic kidney disease progression.
Am J Physiol Renal Physiol. 2025 Feb 1;328(2):F218-F229. doi: 10.1152/ajprenal.00058.2024. Epub 2024 Dec 18.
10
Adamts1 and Cyst Expansion in Polycystic Kidney Disease.
J Am Soc Nephrol. 2025 Apr 1;36(4):559-570. doi: 10.1681/ASN.0000000557. Epub 2024 Nov 8.

本文引用的文献

2
A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis.
Hepatology. 2018 May;67(5):1754-1767. doi: 10.1002/hep.29477. Epub 2018 Jan 29.
3
Inflammation and Fibrosis in Polycystic Kidney Disease.
Results Probl Cell Differ. 2017;60:323-344. doi: 10.1007/978-3-319-51436-9_12.
4
Redox regulation in metabolic programming and inflammation.
Redox Biol. 2017 Aug;12:50-57. doi: 10.1016/j.redox.2017.01.023. Epub 2017 Feb 12.
5
Cell Proliferation and Apoptosis in ADPKD.
Adv Exp Med Biol. 2016;933:25-34. doi: 10.1007/978-981-10-2041-4_3.
6
Tolvaptan suppresses monocyte chemotactic protein-1 excretion in autosomal-dominant polycystic kidney disease.
Nephrol Dial Transplant. 2017 Jun 1;32(6):969-975. doi: 10.1093/ndt/gfw060.
7
Fatty Acid Oxidation is Impaired in An Orthologous Mouse Model of Autosomal Dominant Polycystic Kidney Disease.
EBioMedicine. 2016 Jan 26;5:183-92. doi: 10.1016/j.ebiom.2016.01.027. eCollection 2016 Mar.
9
Three-Dimensional Morphology by Multiphoton Microscopy with Clearing in a Model of Cisplatin-Induced CKD.
J Am Soc Nephrol. 2016 Apr;27(4):1102-12. doi: 10.1681/ASN.2015010079. Epub 2015 Aug 24.
10
Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease.
J Clin Invest. 2015 Jun;125(6):2399-412. doi: 10.1172/JCI80467. Epub 2015 May 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验